company background image
CBAV

Clínica BavieraBME:CBAV Stock Report

Market Cap

€313.0m

7D

4.9%

1Y

120.7%

Updated

23 Oct, 2021

Data

Company Financials
CBAV fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance6/6
Financial Health5/6
Dividends3/6

CBAV Overview

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics.

Price History & Performance

Summary of all time highs, changes and price drops for Clínica Baviera
Historical stock prices
Current Share Price€19.20
52 Week High€8.25
52 Week Low€24.00
Beta0.45
1 Month Change-2.04%
3 Month Change41.18%
1 Year Change120.69%
3 Year Change45.46%
5 Year Change116.70%
Change since IPO-15.27%

Recent News & Updates

Sep 15
These 4 Measures Indicate That Clínica Baviera (BME:CBAV) Is Using Debt Safely

These 4 Measures Indicate That Clínica Baviera (BME:CBAV) Is Using Debt Safely

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Apr 12
Investors Shouldn't Overlook The Favourable Returns On Capital At Clínica Baviera (BME:CBAV)

Investors Shouldn't Overlook The Favourable Returns On Capital At Clínica Baviera (BME:CBAV)

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Shareholder Returns

CBAVES HealthcareES Market
7D4.9%1.0%-0.6%
1Y120.7%13.7%23.8%

Return vs Industry: CBAV exceeded the Spanish Healthcare industry which returned 13.7% over the past year.

Return vs Market: CBAV exceeded the Spanish Market which returned 23.8% over the past year.

Price Volatility

Is CBAV's price volatile compared to industry and market?
CBAV volatility
CBAV Beta0.45
Industry Beta0.97
Market Beta1

Stable Share Price: CBAV is more volatile than 90% of Spanish stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: CBAV's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Spanish stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a736Eduardo Baviera Sabaterhttps://www.clinicabaviera.com

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments.

Clínica Baviera Fundamentals Summary

How do Clínica Baviera's earnings and revenue compare to its market cap?
CBAV fundamental statistics
Market Cap€313.03m
Earnings (TTM)€26.94m
Revenue (TTM)€159.51m

11.6x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CBAV income statement (TTM)
Revenue€159.51m
Cost of Revenue€78.09m
Gross Profit€81.41m
Expenses€54.47m
Earnings€26.94m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)1.65
Gross Margin51.04%
Net Profit Margin16.89%
Debt/Equity Ratio25.9%

How did CBAV perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

33%

Payout Ratio

Valuation

Is Clínica Baviera undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CBAV (€19.2) is trading below our estimate of fair value (€76.85)

Significantly Below Fair Value: CBAV is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: CBAV is good value based on its PE Ratio (11.6x) compared to the European Healthcare industry average (23.8x).

PE vs Market: CBAV is good value based on its PE Ratio (11.6x) compared to the Spanish market (23.2x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CBAV's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CBAV is overvalued based on its PB Ratio (6.1x) compared to the XE Healthcare industry average (2.3x).


Future Growth

How is Clínica Baviera forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Clínica Baviera has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Clínica Baviera performed over the past 5 years?

18.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CBAV has high quality earnings.

Growing Profit Margin: CBAV's current net profit margins (16.9%) are higher than last year (7.8%).


Past Earnings Growth Analysis

Earnings Trend: CBAV's earnings have grown by 18% per year over the past 5 years.

Accelerating Growth: CBAV's earnings growth over the past year (209%) exceeds its 5-year average (18% per year).

Earnings vs Industry: CBAV earnings growth over the past year (209%) exceeded the Healthcare industry 40.8%.


Return on Equity

High ROE: CBAV's Return on Equity (52.6%) is considered outstanding.


Financial Health

How is Clínica Baviera's financial position?


Financial Position Analysis

Short Term Liabilities: CBAV's short term assets (€36.5M) exceed its short term liabilities (€34.0M).

Long Term Liabilities: CBAV's short term assets (€36.5M) do not cover its long term liabilities (€41.7M).


Debt to Equity History and Analysis

Debt Level: CBAV's debt to equity ratio (25.9%) is considered satisfactory.

Reducing Debt: CBAV's debt to equity ratio has reduced from 57.5% to 25.9% over the past 5 years.

Debt Coverage: CBAV's debt is well covered by operating cash flow (288.9%).

Interest Coverage: CBAV's interest payments on its debt are well covered by EBIT (78.8x coverage).


Balance Sheet


Dividend

What is Clínica Baviera current dividend yield, its reliability and sustainability?

2.87%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: CBAV's dividend (2.87%) is higher than the bottom 25% of dividend payers in the Spanish market (1.5%).

High Dividend: CBAV's dividend (2.87%) is low compared to the top 25% of dividend payers in the Spanish market (5.45%).


Stability and Growth of Payments

Stable Dividend: CBAV's dividend payments have been volatile in the past 10 years.

Growing Dividend: CBAV's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (33.4%), CBAV's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.2yrs

Average board tenure


CEO

Eduardo Baviera Sabater (53 yo)

no data

Tenure

€200,000

Compensation

Mr. Eduardo Baviera Sabater serves as the Chief Executive Officer of Clínica Baviera, S.A. and served as its Executive Chairman since February 12 2007 and also served as its Managing Director. Mr. Baviera...


CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Eduardo's total compensation is reasonable compared to companies of similar size in the Spanish market.

Compensation vs Earnings: Eduardo's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: CBAV's board of directors are considered experienced (4.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Clínica Baviera, S.A.'s employee growth, exchange listings and data sources


Key Information

  • Name: Clínica Baviera, S.A.
  • Ticker: CBAV
  • Exchange: BME
  • Founded: NaN
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: €313.026m
  • Shares outstanding: 16.30m
  • Website: https://www.clinicabaviera.com

Number of Employees


Location

  • Clínica Baviera, S.A.
  • Paseo de la Castellana 20
  • Madrid
  • Madrid
  • 28046
  • Spain

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/23 17:46
End of Day Share Price2021/10/22 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.